Bucladesine: Difference between revisions

Bucladesine
Clinical data
ATC code	C01CE04 (WHO) ;
Identifiers
	IUPAC name sodium [(1R,2R,4R,5R)-2-[6-(butanoylamino)purin-; 9-yl]-7-oxido-7-oxo-3,6,8-trioxa-7λ5-; phosphabicyclo[3.3.0]oct-4-yl]methyl butanoate;
CAS Number	362-74-3;
PubChem CID	28177;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C18H23N5NaO8P
Molar mass	491.368 g/mol

Revision as of 23:13, 8 August 2012

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Bucladesine is a phosphodiesterase inhibitor.

@@ Line 25: / Line 25: @@
 {{CMG}}
-{{Editor Join}}
 ==Overview==
 '''Bucladesine''' is a [[phosphodiesterase inhibitor]].

Clinical data

ATC code	C01CE04 (WHO)
Identifiers
IUPAC name sodium [(1R,2R,4R,5R)-2-[6-(butanoylamino)purin- 9-yl]-7-oxido-7-oxo-3,6,8-trioxa-7λ⁵- phosphabicyclo[3.3.0]oct-4-yl]methyl butanoate
CAS Number	362-74-3
PubChem CID	28177
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₁₈H₂₃N₅NaO₈P
Molar mass	491.368 g/mol